We demonstrated the contribution of gp130 signalling to tumour growth in vivo, using human colon cancer xenografts and that the gp130 receptor specifically mediates BZA treatment-associated inhibition of human colon cancer cell proliferation. The gene discussed is IL6ST; the disease is malignant colon neoplasm.